Screener
Surgery Partners, Inc. SGRY Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 11.4%+0.2pp | 11.8%+1.2pp | 11.8%+0.6pp | 12.4%+1.5pp | 11.2%-0.8pp | |
| Net margin | -2.6%+2.9pp | -2.3%+3.8pp | -2.4%+3.0pp | -5.2%-3.2pp | -5.6%-4.4pp | |
| Returns | ||||||
| Return on equity | -5.2%+4.6pp | -4.4%+6.0pp | -4.4%+4.5pp | -9.5%-6.3pp | -9.7%-8.0pp | |
| Return on invested capital | 5.9%+0.1pp | 6.1%+0.6pp | 6.2%+0.2pp | 6.5%+0.9pp | 5.9%-0.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.9×0.0× | 1.9×0.0× | 1.9×+0.1× | 1.9×+0.1× | 1.9×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3×+0.2× | 3×+0.2× | 3×+0.4× | 2.8×+0.5× | 2.8×+0.6× | |
| Net debt / EBITDA | 8.7×-0.2× | 8.5×-0.9× | 8.5×-0.1× | 8.4×-0.3× | 8.9×+0.4× | |
| Per Share | ||||||
| Book value per share | $12.97-5.8% | $13.15-4.3% | $13.47-5.1% | $13.60-9.5% | $13.77-11.1% | |
| Valuation | ||||||
| Market capitalization | $1.73B-36.3% | $1.54B-49.1% | $2B-25.7% | $2.77B-31.8% | $2.71B-9.7% | |
| Price / sales | 0.5×-0.3× | 0.5×-0.5× | 0.6×-0.3× | 0.8×-0.5× | 0.8×-0.2× | |
| Price / book | 1×-0.5× | 0.9×-0.8× | 1.2×-0.3× | 1.6×-0.5× | 1.5×0.0× | |
| EV / EBITDA | 11.8×-1.5× | 11.2×-4.4× | 12.1×-2.0× | 13.4×-3.9× | 14.1×-0.8× |
FAQ
- What are Surgery Partners, Inc.'s profit margins?
- Surgery Partners, Inc. (SGRY) runs a 23.1% gross margin and a 11.4% operating margin, with a -2.6% net margin.
- Where do Surgery Partners, Inc.'s ratios come from?
- Every ratio is computed from Surgery Partners, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
